Advancing Evidence-Based Treatments
To expand therapy options, availability, and access, FDA is:
- Expanding availability and access to evidence-based treatments for substance use disorders
- Facilitating development of treatments for substance use disorders, with focus on stimulant use disorder
- Facilitating opportunities to incorporate stakeholder engagement into treatment development
United States Government Partners
- Department of Health & Human Services (HHS)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- Drug Enforcement Administration (DEA)
- National Institutes of Health (NIH)
- Substance Abuse and Mental Health Services Administration (SAMHSA)
- Indian Health Service (IHS)
- Veterans Affairs (VA)